A randomised double blind controlled study of the effects of methylphenidate on Central Audition Deficits

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN35253389

Enrollment

Registered

2002-11-06

Start date

2002-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Audition Deficit (Central Auditory Processing Disorder [CAPD]) Nervous System Diseases

Interventions

Retesting the central audition on methylphenidate or placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Sixty-two consecutive attendees at a university clinic for communication disorders referred for evaluation of learning and listening problems at school by parents, teachers or family physicians and shown to have deficits of Central Audition on a Willeford standardised test battery

Exclusion criteria

Exclusion criteria: Does not match inclusion criteria

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration.	—

Secondary

Measure	Time frame
Not provided at time of registration.	—

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026